Why Disclosure Policies Don’t Discourage Academe’s Drug Salesmen

July 03, 2017 Premium content for subscribers. Subscribe Today

The practice of drug-company payments to scientists to help promote their products remains widespread, despite persistent efforts by universities and the government to check it.

This content is available exclusively to Chronicle subscribers